Growth factors and estrogen receptor (ER) signaling cooperate to play essential roles in cell proliferation, differentiation and tumor progression in mouse reproductive organs. Treatment of neonatal mice with diethylstilbestrol (DES) induces an estrogen-independent persistent proliferation and cornification of the vaginal epithelium, which results in cancerous lesions later in life. However, the mechanisms of the estrogen-dependent andindependent pathways essentially remain unknown. We characterized the expression of epidermal growth factor (EGF)-like growth factors (EGF, transforming growth factor a (TGF-a), heparin-binding EGF-like growth factor (HB-EGF), betacellulin (BTC), amphiregulin (APR), epiregulin (EPR) and neuregulin (NRG) 1) and erbB receptors (EGF receptor (EGFR), erbB2/neu, erbB3 and erbB4) in the vaginae of mice treated either neonatally (0-4 day) or as adults (55-59 day) with estrogens. EGFR and erbB2 were activated in the vaginal epithelium of mice by estrogen treatment. This activation was also encountered in vaginae from neonatally DES-exposed mice, along with the expression of EGF, TGF-a, HB-EGF, BTC, APR, EPR and NRG1. Immunohistochemical analysis indicated that erbB2 was primarily expressed in vaginal epithelium. Finally, we found that serine 118 and 167 located in the AF-1 domain of ERa were phosphorylated in these vaginae. AG825, AG1478 or ICI 182,780 administration blocked proliferation of vaginal epithelium induced by neonatal DES exposure. Thus, signal transduction via EGFR and erbB2 could be related to the estrogen-induced vaginal changes and persistent erbBs phosphorylation and sustained expression of EGF-like growth factors, leading to ERa activation that may result in cancerous lesions in vaginae from neonatally DES-exposed mice later in life.
Introduction
The proliferation and differentiation of mouse vaginal epithelial cells are strongly regulated by ovarian estrogens, such as 17b-estradiol (E 2 ). The vaginae of ovariectomized (OVX) mice show an atrophied epithelium of 2-3 cell layers, but estrogen administration rapidly induces epithelial cell proliferation, stratification and cornification. In rodents, crosstalk between growth factor signaling and estrogen receptor a (ERa) contribute to estrogen action in uterus and vagina. Epidermal growth factor (EGF) has mitogenic effects on the mouse uterus similar to estrogens (Ignar-Trowbridge et al., 1992) in that administration of EGF or transforming growth factor a (TGF-a) to OVX adult mice induces cell proliferation and differentiation in the female reproductive tracts (Nelson et al., 1991 . However, in ERa-deficient mice, both estrogen and EGF stimulation of uterine growth was disrupted (Curtis et al., 1996) . EGF-like growth factors are composed of EGF, TGF-a, heparin-binding EGF-like growth factor (HB-EGF), betacellulin (BTC), amphiregulin (APR), epiregulin (EPR) and neuregulins (NRGs) and interact with the erbB receptor tyrosine kinases: EGF receptor (EGFR)/erbB1, erbB2/neu, erbB3 and erbB4. The members of the erbB receptor family interact as homo-or heterodimers upon ligand binding, which leads to the crossactivation of the receptors. ErbBs have the potential to recruit and activate interacting proteins, thereby initiating signaling cascades that culminate in distinct cellular responses, such as cell proliferation, differentiation and morphogenesis. Overexpression of erbBs is associated with carcinogenesis in the reproductive organs (Dickson and Lippman, 1995) and erbB2 is frequently amplified and overexpressed in cancer cells (Hynes and Stern, 1994) .
Epidemiological and laboratory studies have shown that estrogens are important for the normal proliferation that occurs in reproductive organs. Moreover, longterm estrogenic stimulation is a well-known risk factor for carcinogenesis in human reproductive organs (Marselos and Tomatis, 1992a) . Beginning in the 1940s, a synthetic estrogen, diethylstilbestrol (DES) was routinely prescribed to pregnant women for the prevention of miscarriages. To date, it is well known that in utero exposure to DES induces vaginal clear-cell adenocarci-noma in young women (Herbst et al., 1971) and various malformation in the reproductive tracts (Marselos and Tomatis, 1992a; Herbst, 2000) . In males, in utero DES exposure is associated with an increased risk of testicular cancer and epididymal cysts (Marselos and Tomatis, 1992a; Herbst, 2000) . Like humans, perinatal female mice exposed to natural or synthetic estrogens develop estrogen-independent persistent cell proliferation, stratification and cornification of the vaginal epithelium, resulting in hyperplastic lesions and vaginal cancer later in life (Takasugi et al., 1962; Dunn and Green, 1963; Forsberg, 1979; McLachlan et al., 1980; Iguchi, 1992 ). This rodent model, which simulates the effects of developmental DES exposure in humans, has been characterized, yet the underlying mechanisms remain poorly understood. This irreversible proliferation and differentiation of the vaginal epithelium may be attributable to estrogen-independent, persistent activation of downstream growth factor expression. Indeed, high levels of EGF and TGF-a are expressed in the vaginae of DES treated mice, even after ovariectomy (Nelson et al., 1994; Sato et al., 1996a) . However, the role of crosstalk between erbB signaling and ER in estrogen-independent effects induced by neonatal DES treatment has not yet been elucidated.
Cell proliferation in reproductive organs is tightly regulated by hormones, particularly estrogens. Tumors of reproductive organs can exhibit 'hormone-independent cell proliferation'. Thus, the vaginae of mice exposed neonatally to estrogens can be used as a model system to understand the mechanisms leading to the change from normal to aberrant cell proliferation and differentiation, and tumor formation in vivo. The importance of growth factor induction of ER transcriptional activity in normal physiology and in tumor progression is essentially unknown. In this report, we characterized estrogen-independent vaginal epithelial cell proliferation and differentiation by focusing on the crosstalk between erbBs signaling and ERa. We found that neonatal DES treatment led to increased phosphorylation of EGFR, erbB2 and ERa persistently. These phosphorylations are each capable of activating the receptors in a ligand-independent manner, suggesting a possible mechanism whereby neonatal DES treatment leads to persistent, estrogen-independent proliferation of the vaginal epithelium.
Results

Expression of EGF-like growth factors
We quantified the time-course mRNA expression of growth factors (EGF, TGF-a, HB-EGF, BTC, APR, EPR, insulin-like growth factor (IGF)-I, IGF-II and keratinocyte growth factor (KGF)) in 60-day-old OVX mice after a single injection of E 2 by quantitative realtime RT-PCR (Q-PCR) (see Figure 1 for experimental design). Although it has been reported that estrogen administration induces EGF and TGF-a mRNA expression in mouse uterus (DiAugustine et al., 1988; Nelson et al., 1992) , a single injection of E 2 did not induce significant changes in the expression of growth factor genes in vagina. APR mRNA was the highest Figure 1 Treatment timelines. (a) Female newborn mice were given five daily injections of 2.5 mg DES/kg BW or the vehicle alone from day 0 (the day of birth). They were OVX on day 46 and killed on day 60. (b) To examine the effects of DES on adult mouse vagina, intact mice were OVX on day 46 and given five daily injections of 2.5 mg DES/kg BW from day 55, then killed 24 h after the last injection. (c) Effects of E 2 or EGF on phosphorylation of erbB2, EGFR and ERa were examined in OVX adult mice 0.5, 1, 3, 6, 12 and 24 h (E 2 ) or 15 min (EGF) after a single injection of 50 mg E 2 or 50 mg EGF/kg BW. (d) Three injections of AG825 or AG1478 (5 mg/kg BW) were administered every 8 h. BrdU was injected at the last injections of AG825 or AG1478, and killed 1 h later. (e) 4-OHT and ICI (5 mg/kg BW/day) were administered to mice that had been OVX on day 46 for 7 days from days 60 to 66, and then killed 24 h after the last injection Estrogen-independent activation of erbBs and ERa S Miyagawa et al among E 2 -responsive growth factors in this study (Figure 2a) . We also quantified the expression level of mRNAs encoding ligands for erbB receptors in vaginae of oiltreated OVX control, 60-day-old OVX mice after five daily injections of DES (adultDES) and 60-day-old OVX mice treated neonatally with DES for 5 days (neoDES mice). In neoDES vaginae, all ligands for erbB receptors were highly expressed (Figure 2b ). Successive DES treatments induced the expression of erbBs in adultDES vaginae that closely resembled that seen in neoDES vaginae, but the magnitude of the induction was lower (Figure 2b ). The NRGs primarily bind to erbB3 and erbB4 and have been shown to be a complex gene family with many alternatively spliced forms. Therefore, we examined NRG1 transcript expression by RT-PCR and gel electrophoresis to allow detection of splicing variants. NRG1 transcripts were expressed in both adultDES and neoDES vaginae, with adultDES tissue showing higher expression levels (Figure 2c ).
IGF-I signaling is involved in E 2 -induced responses, such as epithelial cell proliferation in rodent uterus (Klotz et al., 2000) ; therefore, we also examined IGF-I mRNA expression. In mouse vagina, a single injection of E 2 induced IGF-I mRNA expression in a timedependent manner (Figure 2a) . In adultDES and neoDES vaginae, IGF-I mRNA levels were not altered when compared to controls. Similarly, other growth factors, IGF-II and KGF did not show changes in mRNA expression in vaginae from adultDES nor neoDES mice (Figure 2b ) and OVX mice given a single injection of E 2 (data not shown). Although we do not exclude a possible role of IGF-I in vaginal responses, persistent vaginal epithelial cell proliferation and differentiation is mainly contributed by ligands of erbB receptors in neoDES vagina.
To study the tissue distribution of growth factors, epithelium and stroma were separated by incubating in a trypsin solution, and followed by RT-PCR analysis. Excluding NRG1, which was expressed in the stroma only, the other ligands were primarily expressed in the epithelium. In particular, APR and EPR were only detected in the epithelium (Figure 2d ).
ErbB mRNA and protein expression in vagina
We confirmed the expression of mRNAs encoding all four erbB types in both adult and neonatal mouse vagina by RT-PCR (data not shown) and the erbB proteins by immunoblot analysis (Figure 3a ). Q-PCR was employed to quantitate the response of the erbB mRNAs to DES treatment. In vaginae of adultDES, there was no significant decrease in the expression of erbB mRNAs (Figure 3b ). In contrast, EGFR and erbB2 mRNA expression was significantly decreased in neoDES vaginae (Figure 3b ). Reduction of EGFR expression following neonatal DES exposure has been reported previously (Iguchi et al., 1993) . However, we have now observed that erbB2 expression was also significantly decreased in neoDES vagina. ErbB3 and erbB4 mRNA levels also appeared to decrease but these changes were not statistically significant. We also assessed the expression of erbB mRNAs in vaginae Estrogen-independent activation of erbBs and ERa S Miyagawa et al from 5-day-old mice and found that successive DES treatment from the day of birth suppressed the expression of erbB2 mRNA (data not shown). The expression of EGFR and erbB4 mRNAs was slightly, but not significantly decreased ( Figure 3b ). ErbB2 protein expression was slightly reduced in neoDES vaginae ( Figure 3a) . Thus, erbB2 downregulation appears to be correlated with vaginal tissue morphology.
Phosphorylation of erbB2 and EGFR in vagina
The phosphorylation status of erbB2 in vaginae from adultDES and neoDES mice was examined using antiphospho-erbB2 antibody, which recognizes phosphotyrosine 877 from human protein sequences. Phospho-erbB2 was detected in vaginae from both adultDES and neoDES mice but not in vaginae from controls, although erbB2 protein was expressed in controls ( Figure 3c ). Tyrosine 845 of EGFR was also phosphorylated in vaginae of neoDES and adultDES mice ( Figure 3c ). Taken together, these data suggest that DES treatment induces phosphorylation of erbB2 and EGFR, which would be expected to upregulate the downstream signaling pathways under their control. Considering the correlation between DES treatment and erbB2 expression, we next investigated the distribution of erbB2 mRNA in mouse vagina using immunohistochemistry. Intense membrane staining for erbB2 was observed in epithelial cells of vaginae from 60-dayold OVX mice. Apical cells were more strongly stained than basal cells whereas stromal cells beneath the basement membrane were weakly stained ( Figure 4a ).
In neoDES vaginae, erbB2 immunostaining was found in basal epithelial cells, whereas the differentiating cells that migrated toward the surface of the epithelium exhibited decreased erbB2 expression (Figure 4b ). Stromal cells were not stained (Figure 4b ). Immunoreactivities were abolished by incubation with control rabbit IgG demonstrating the specificity of the erbB2 staining (Figure 4c) .
The time course of erbB2 phosphorylation was examined in vaginae from 60-day-old OVX mice after a single injection of E 2 . Phospho-erbB2 was transiently detected in vaginae 12 h after E 2 injection (Figure 4d ). The phosphorylation pattern of EGFR was similar to that observed for erbB2 (Figure 4d ). These data suggested the existence of a crosslink between erbB2 phosphorylation and estrogen action in the mouse vagina.
Phosphorylation of ERa in vagina
To investigate the downstream of erbB2 and EGFR phosphorylation further, we tested whether increased erbB signaling would affect downstream target genes. ErbBs activation derived from administration of EGF, the most well-known ligands for erbBs, leads to vaginal epithelial cell proliferation and differentiation in OVX mice (Nelson et al., 1991) . It is known that erbBs can stimulate the transcriptional activity of ERa by phosphorylating serine 118 and 167 of this receptor (located within the AF-1 region) through mitogen-activated protein kinase (MAPK) and/or Akt cascades (Lannigan, 2003) . Actually, EGF administration led to phosphorylation of ERa with erbB2 and EGFR activation in vagina (Figure 5a ).
ERK1/2 exhibited a high basal level of phosphorylation even in OVX mice, and phosphorylation of ERK1/ 2 above basal levels did not occur in adultDES and neoDES vaginae as previously reported using uterine tissue from mice (Klotz et al., 2002) . However, p90 ribosomal S6 kinase (RSK), which is one of the substrates for ERK1/2 and can phosphorylate ERa (Joel et al., 1998) , was activated in neoDES and adultDES vaginae (Figure 5b ). Furthermore, both serine residues of ERa were phosphorylated in neoDES and adultDES vaginae (Figure 5c ), confirming that erbBs phosphorylation could lead to the activation of ERa independently of the continuing presence of estrogens in vaginal epithelium. Detectable levels of ERa are present in both stromal and epithelial compartments of the vaginae obtained from neonatally DES-treated mice (Sato et al., 1996b) . After tissue separation by trypsin, we weakly detected total and phosphorylated ERa protein in vaginal epithelial tissue, but in stromal tissue, we could not detect even total ERa protein due to the long trypsin incubation (data not shown).
We examined AF-1 function of ERa in mouse vagina using 4-hydroxytamoxifen (4-OHT), which acts as an agonist for AF-1, but as an antagonist for AF-2 (Berry et al., 1990; McDonnell et al., 1995; Metzger et al., 1995) . Administration of 4-OHT to intact OVX mice induced vaginal epithelial stratification and cornification (Figure 5d ). These data indicated that only AF-1 activation of ERa induced ligands for erbB receptors. Further, ERa and erbB signaling formed on activation loop without E 2 , which initially must regulate this signaling pathway.
This hypothesis was supported by the experiment using inhibitors of EGFR (AG1478) and erbB2 (AG825). The number of BrdU-incorporated cells was slightly and significantly reduced in neoDES vagina treated with AG825 and AG1478, respectively ( Figure  6a-c) . The level of phosphorylation of ERa, in particular Ser 118, was also reduced in these vaginae treated with the inhibitors (Figure 6d ).
Effects of ICI 182,780 in NeoDES vagina
We next tested whether ICI 182,780 (ICI), an antagonist for both AF-1 and AF-2 of the ERa, could block the irreversible effects in neoDES vaginae. As shown in Table 1 and Figure 7 , ICI administration partially blocked epithelial differentiation, accompanied by low expression of growth factors, erbB receptors and their phosphorylation levels in neoDES vagina killed 24 h after the last ICI injection. These data confirm that deregulation of AF-1 leads to estrogen-independent ERa action. Administration of ICI to intact OVX mice did not induce vaginal epithelial stratification (data not shown).
Discussion
Integrated hormonal signaling networks modulate the reproductive systems in animals. E 2 is responsible for Estrogen-independent activation of erbBs and ERa S Miyagawa et al promoting estrus, influences the development and maintenance of female sex characteristics, including the induction of behavioral and physiological processes in a variety of organ systems. Like most hormones, E 2 exhibits acute and transient actions in its target organs. For example, E 2 administration increases organ weight and promotes cell proliferation and differentiation in the adult female reproductive tracts (Iguchi et al., 1986) . E 2 withdrawal induces rapid involution of uteri and vaginae, resulting in atrophy (Sato et al., 2003) . This reversible and specific effect of E 2 is important in maintaining homeostasis and is required for normal health and reproduction. In contrast, long-term exposure to estrogens induces an imbalance in cell proliferation and increases the risk of cancer of the reproductive organs in rodents and humans (Marselos and Tomatis, 1992a, b) . It was reported that in utero exposure to DES caused vaginal clear-cell adenocarcinoma in a subset of exposed females (Herbst et al., 1971) . To help understand this phenomenon, a laboratory rodent model has been characterized; mice treated neonatally with DES develop estrogen-independent proliferation and cornification in the vaginal epithelium and tumors later in life (Takasugi, 1976; Forsberg, 1979; Iguchi, 1992) . Since the differentiative response of the vaginal epithelium is complex and involves the generation and differentiation of multiple suprabasal layers, an appropriate in vitro system for studying vaginal epithelium has not been established. For example, isolated vaginal epithelium in vitro fails to stratify or cornify in response to E 2 (Iguchi et al., 1983; Tsai et al., 1991) . Therefore, to elucidate mechanisms of estrogen-dependent and -independent effects, which involve the induction of tumors, we used neonatal DES-treated mice as a model system. The present study was focused on the signaling of ER and erbBs and their ligands, the EGF-like growth factors in mouse vagina, since many cancers of estrogen-target organs can be related to these factors (Kurokawa et al., 2000; Atanaskova et al., 2002) . Although many growth factors have been reported to be related to reproductive organ growth, EGF-like growth factors were hypothesized as major factors involved in estrogen-dependent and -independent growth. It is notable that HB-EGF, APR and EPR were expressed at higher levels than EGF or TGF-a, which are considered to be powerful mitogens in the reproductive tracts of adult mouse (Nelson et al., 1991) . Interestingly, it was reported that APR was induced by progesterone but not by estrogens in rodent uterus (Das et al., 1995) . On the contrary, APR contributed to the autocrine growth of keratinocytes and tumor progression (Normanno et al., 1994; Piepkorn et al., 1994) . This is the first report that APR is an estrogen-inducible growth factor and may be involved in vaginal epithelial cell growth, such as stratification and cornification. The sustained expression of other growth factors may be induced by APR, as EGF-like growth factors are capable of inducing other EGF-like growth factors, the so called crossinduction (Hashimoto et al., 1994) .
In addition to increased EGF-like growth factors, neonatal DES treatment led to increases in phosphorylation of EGFR and erbB2 even after ovariectomy. The erbB family has been implicated in numerous physiological processes and is generally regarded as a major contributor to cell proliferation and tumor progression. Amplification or overexpression of erbB2 has been reported in various cancer cells (Hynes and Stern, 1994) , thus it is expected that erbB mRNAs would be increased in vaginae from neoDES mice. Instead, we observed a reduction of EGFR and erbB2 mRNA and protein expression in vaginae from both neoDES and adultDES mice, accompanied by an increase in phosphorylations of these receptor proteins. Phosphorylation of erbB2 is probably due to ligand binding and ultimately results in downregulation of the receptor, a property commonly known to receptor tyrosine kinases (Pastan and Willingham, 1983) . ErbB expression in neoDES vaginae was quite similar to that in adultDES vaginae, even in the absence of stimulation by estrogens. It should be noted that although erbB expression differs between neoDES vaginae and vaginal tumors, persistent phosphorylation and activation of erbB2 have been suggested to be an early stage in tumor formation. Although all erbBs were expressed in mouse vagina and have the potential as mediators of estrogen action, EGFR likely interacts with erbB2 since we found that both EGFR and erbB2 were phosphorylated in neoDES vaginae, erbB2 is expressed in the vaginal epithelium and it was previously reported that EGFR was expressed in mouse vaginal epithelium (Falck and Forsberg, 1996) .
Finally, we found that ERa is phosphorylated at serine 118 and 167 within the AF-1 domain in neoDES vaginae. Phosphorylation of these residues regulates estrogen-independent transactivation by the receptor. The activity of the ERa AF-1 domain is ligand Estrogen-independent activation of erbBs and ERa S Miyagawa et al independent and constitutive, whereas the function of AF-2 in the ligand-binding domain is dependent on ligand binding. When E 2 dissociates from the receptor, ERa becomes transcriptionally inactive because the potential function of the AF-1 is suppressed by the unliganded ligand-binding domain (Kato et al., 2000) . Phosphorylation of the AF-1 domain in mouse ERa also affects the transcriptional function of AF-2 (Lahooti et al., 1995) . It is well established that growth factors can activate ERa in the absence of its ligand through phosphorylation in AF-1 (Kato et al., 1998; Yee and Lee, 2000) . Although participation of other growth factor signaling pathways cannot be ignored, erbBs can activate AF-1 of ERa by MAPK and Akt cascades (Lannigan, 2003) . In our study, activated erbB signal induced ERa phosphorylation via at least p90RSK, which has the potential to phosphorylate serine 167 of ERa (Joel et al., 1998) , while phosphorylated ERa induces EGF-like growth factors, which activates erbB receptors. Thus, estrogen-independent actions in the vagina were characterized by the formation of an activation loop between ERa and erbB signaling.
Normal E 2 -induced epithelial proliferation in the vagina is mediated through stromal ERa (Buchanan et al., 1998) , and the alterations in stromal-epithelial interactions may lead to the onset and/or progression of carcinogenesis. In our study, epithelial cells in neoDES vagina seem to exhibit direct mitogenic and differentiation responses in epithelial cells, and they lose their normal stromal association. Actually, tissue recombinant experiments showed that the reciprocal recombination of neonatally estrogenized vaginal epithelium and untreated vaginal stroma exhibited ovary-independent hyperplasia (Cunha et al., 1977) . This is the first report that ligand-independent ER action induces a precancerous status in estrogen-target organ in vivo.
It has not been determined whether a major contributor to estrogen-independent effects in neoDES vaginae are the erbBs or the ER. Our study demonstrated that, at least, ERa might be critical for estrogenindependent vaginal changes in neoDES mice, even in the absence of estrogen. AF-1 activation following the administration of 4-OHT induced expression of ligands for erbB receptors in vaginae. Furthermore, the administration of ICI to neoDES mice blocked phosphorylation of EGFR and erbB2, resulting in a reduction in the number of vaginal epithelial cell layers. As to erbBs, the administration of EGF rapidly induced the phosphorylation of ERa in the present study. The administration of EGF leads to vaginal cell proliferation and differentiation (Nelson et al., 1991) . Thus, erbBs play roles in the phosphorylation of ERa and mediation of ER action in vaginal cells. We also demonstrated that inhibitors of erbBs blocked or slightly reduced BrdU incorporation and ERa phosphorylation of serine 118 in neoDES mice. These data suggests that ERa and erbBs make a crosstalk and form activation loop, then it leads to estogen-independent activation in neoDES vagina.
The mechanisms driving the constitutive activation of ERa that occurs only in neoDES mice remain unknown. DES activates both ERa and erbBs in the vagina of normal adult mice in the similar manner to that observed in the neoDES mice. However, the activation loop has not been established in the normal adult mice and the effect of estrogen is always reversible. Additional factors, such as dysregulation of phosphatase or signals through other receptor tyrosine kinases may be involved in the persistent proliferation and differentiation of vaginal epithelial cells.
Estrogen signals acting through ERa cause both proliferation and differentiation of the vaginal epithelial cells. While hyperproliferation leads to cancer, the superactivation of differentiation signal may prevent cancer development. The balance of these two signaling cascades seems to be an important factor in estrogeninduced cancers. The constitutive activation of the ERaerbB signaling loop seems to induce both proliferation and differentiation. Hence, an alternation in this activation loop may shift the tissue response toward more proliferation than differentiation during carcinogenesis. Therefore, further analyses are needed in order to clarify the activation status of ERa and erbB family members in the precancerous and cancer stages.
Despite decades of research, the mechanisms by which developmental exposure to estrogens results in persistent alteration of growth and differentiation of reproductive tracts in humans and rodents remain unknown. As generation of women exposed to DES becomes older, with the possibility of a second rise in DES-associated vaginal clear-cell adenocarcinoma (Herbst, 2000) . Various studies to date have shown that DES-like effects can be induced following exposure to xenoestrogens in laboratory animals and wildlife (McLachlan, 2001) . Therefore, further characterization of the DES model is needed to advance our knowledge of the potential risk of the carcinogenetic effects of estrogens, including developmental effects of xenoestrogens. In conclusion, we demonstrated that estrogen-independent pathway required for ERa, and activation of crosstalk between erbBs signaling and ER leads to ligand-independent activation of ERa which, in turn, leads to persistent, estrogen-independent vaginal changes and may lead to cancer in the mouse vagina later in life.
Materials and methods
Animals and treatments
Female C57BL/6J mice were maintained under 12 h light/12 h dark at 23-251C and fed laboratory chow (CA-1, CLEA, Tokyo, Japan) and tap water ad libitum. All procedures and protocols were approved by the Institutional Animal Care and Use Committee at the National Institute for Basic Biology, Okazaki National Research Institutes.
Treatment time lines are shown in Figure 1 . Female newborn mice were given a daily subcutaneous (s.c.) injection of 2.5 mg DES (Sigma, St Louis, MO, USA)/kg body weight (BW)/day dissolved in sesame oil or the vehicle alone beginning from days 0 (the day of birth) to 4. Some mice were killed 24 h after the last injection, and others were OVX at day 46 and killed at day 60 (referred to as neoDES mouse) (Figure 1a) . Subsets of these mice were administered three injections of AG825 or AG1478 (Tocris, Ellisville, MO, USA) (5 mg/kg BW) dissolved in dimethyl sulfoxide (DMSO), at 8 h intervals. BrdU (50 mg/kg BW) (Sigma) was injected at the last injection of the inhibitors and killed 1 h later (Figure 1d) . The other subset of mice were administered with daily 4-OHT (Sigma) or ICI 182,780 (ICI, Tocris) (5 mg/kg BW/day) dissolved in sesame oil for a week and killed 24 h after the last injection (Figure 1e) . To examine the acute and reversible effects of estrogens on the vagina, untreated mice were OVX at day 46 and treated with a daily injection of 2.5 mg DES/kg BW/ day for 5 days, then killed 24 h after the last injection (referred to adultDES mouse) (Figure 1b) . This treatment was sufficient to induce stratified and keratinized vaginal epithelium in OVX mice. For examining direct effects of estrogen and EGF, a single injection of 50 mg E 2 (Sigma) or 50 mg EGF (Biomedical, Stoughton, MA, USA)/kg BW was given to 60-day-old mice, which were OVX on day 46, and killed 0.5, 1, 3, 6, 12 and 24 h (E 2 ) or 15 min (EGF) after the injection (Figure 1c) .
For tissue separation, neoDES vagina were cut into small pieces, placed into 1% trypsin (Difco, Kansas, MO, USA) in Hanks' balanced salt solution (Invitrogen, Carlsbad, CA, USA) and digested at 41C for 90 min. The vaginal epithelium and stroma were then separated mechanically using fine surgical forceps.
Immunohistochemistry and BrdU immunostaining
Tissues were fixed in neutral buffered 10% formalin, embedded in paraffin and sectioned at 6 mm. Deparaffinized sections were incubated in 0.3% H 2 O 2 in methanol for 15 min to eliminate endogenous peroxidases. After washing with PBS, the sections were stained with Histofine (Nichirei, Tokyo, Japan) according to the manufacturer-supplied protocol. AntierbB2 antibody was obtained from Novocastra (Newcastle, UK). The sections were incubated at a 1 : 500 dilution in PBS containing 1% BSA (Sigma) for 60 min at room temperature. For negative controls, normal rabbit immunoglobulin fraction (Dako, Carpinteria, CA, USA) at the same dilution of each antibody was used.
For BrdU-immunostaining, deparaffinized, sections were incubated in 3% H 2 O 2 in methanol for 30 min and immersed in 2 N HCl for 20 min in order to denature the genomic DNA. After washing with PBS, the sections were incubated with antiBrdU antibody (Boehringer Mannheim, Mannheim, Germany) diluted 1 : 10 in PBS containing 1% BSA for 60 min at room temperature. The sections were subsequently incubated with 3,3-diaminobenzidine tetrahydrochloride containing hydrogen peroxide. BrdU-labeling index was estimated by counting the number of BrdU-incorporated cells in the vaginal epithelial basal layer. Statistical analysis was performed using Student's t-test or Welch's t-test followed by F-test.
RT-PCR
Changes in gene expression were confirmed and quantified using Q-PCR with the ABI Prism 5700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA). Total RNA (2.5 mg), isolated with an RNeasy kit (QIAGEN, Chatsworth, CA, USA) from each groups, was used in RT-PCR reactions carried out with SuperScript II reverse transcriptase (Invitrogen) and SYBR Green Master Mix (Applied Biosystems) according to the manufacturer's instructions. PCR conditions were as follows: 501C for 2 min, 951C for 10 min, and 40 cycles of 951C for 15 s and 601C for 1 min in 15 ml volumes. Sequences of gene primer sets are given in Table 2 . Relative RNA equivalents for each sample were obtained by standardization of ribosomal protein L8 (L8) levels. More than three pools of samples per group were run in triplicate to determine sample reproducibility, and the average relative RNA equivalents per sample was used for further analysis. Error bars represent the standard error, with all values represented as fold change compared to the control treatment group normalized to an average of 1.0. Statistical analysis was performed using Student's t-test or Welch's t-test followed by F-test; differences with Po0.05 were considered significant.
The expression of NRG1 was examined using RT-PCR following electrophoresis. The annealing temperature was 601C and 31 cycles for NRG1 and 24 cycles for glyceraldehyde-3-phosphate dehydrogenase.
Protein preparation and immunoblotting
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